EOB 2024-2025
Select a Country
Collaboration strengthened to advance technical cooperation
During the 2024–2025 biennium, PAHO advanced discussions with the French authorities and partners to address key priorities. Progress was made in developing the necessary framework agreements and partnerships to advance technical cooperation.
[Report Landing Page]
Outcome Indicators
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases | Target 2025 | No rating |
| 04.j. Number of countries and territories that have incorporated HPV vaccines in their national vaccination program | Baseline 2019 | No rating |
| 17.b. Number of countries and territories with >80% of malaria cases investigated and classified in areas targeted for elimination or prevention of reestablishment | Baseline 2019 | No rating |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context | Target 2025 | No rating |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies | Baseline 2019 | No rating |
| Outcome Indicator | Baseline/Target | Rating |
|---|---|---|
| 27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues | Target 2025 | No rating |
| 27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025 | Target 2025 | No rating |
4. Response capacity for communicable diseases
Communicable diseases
04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases
04.f. Number of countries and territories with capacity to conduct integrated surveillance of arbovirus cases
Target Value:
2025
Baseline value:
2019
Rating:
Partially achieved
Communicable diseases
04.j. Number of countries and territories that have incorporated HPV vaccines in their national vaccination program
04.j. Number of countries and territories that have incorporated HPV vaccines in their national vaccination program
Target Value:
2025
Baseline value:
2019
Rating:
Achieved
17. Elimination of communicable diseases
Communicable diseases
17.b. Number of countries and territories with >80% of malaria cases investigated and classified in areas targeted for elimination or prevention of reestablishment
17.b. Number of countries and territories with >80% of malaria cases investigated and classified in areas targeted for elimination or prevention of reestablishment
Target Value:
2025
Baseline value:
2019
Rating:
Partially achieved
21. Data, information, knowledge, and evidence
Information systems, evidence, and research
21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context
21.b. Number of countries and territories that generate, analyze, and use data and information according to health priorities, disaggregated by geopolitical and demographic strata, as appropriate to the national context
Target Value:
2025
Baseline value:
2019
Rating:
Partially achieved
23. Health emergencies preparedness and risk reduction
Health emergencies
23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies
23.a. Number of countries and territories that meet or exceed minimum capacities to manage public health risks associated with emergencies
Target Value:
2025
Baseline value:
2019
Rating:
Not achieved
27. Leadership and governance
Leadership, governance, and enabling functions
27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues
27.a. Proportion of countries and territories where the national health authority reports satisfaction with PAHO/WHO’s leading role on global and regional health issues
Target Value:
2025
Baseline value:
2019
Rating:
Partially achieved
Leadership, governance, and enabling functions
27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025
27.b. Number of countries and territories for which there is alignment between the national health policy, strategy, or plan and the outcomes defined in the PAHO Strategic Plan 2020-2025
Target Value:
2025
Baseline value:
2019
Rating:
Partially achieved
Output Indicators
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus | Baseline 2023 | No rating |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics | Target 2025 | No rating |
| Output (OPT) Indicator | Baseline/Target | Rating |
|---|---|---|
| 24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19 | Baseline 2023 | No rating |
17.5 The Region of the Americas maintained free of poliomyelitis
Communicable diseases
17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus
17.5.a. Number of countries and territories that have maintained their status as free from both wild poliovirus and circulating vaccine-derived poliovirus
Baseline value
2023
Target Value
2025
Rating:
Partially achieved
20.2 Countries and territories enabled to adand implement national plans of action for strengthening the quality and coverage of vital statistics
Information systems, evidence, and research
20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics
20.2.a. Number of countries and territories implementing an updated plan of action for strengthening the quality and coverage of vital statistics
Baseline value
2023
Target Value
2025
Rating:
Not achieved
24.3 Countries and territories enabled to mitigate the risk and consequences of the emergence/reemergence of high-threat infectious pathogens, including emerging zoonotic pathogens, and to improve pandemic preparedness
Health emergencies
24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19
24.3.c. Number of countries and territories with operational integrated surveillance systems and pandemic preparedness plans for respiratory viruses, including influenza and COVID-19
Baseline value
2023
Target Value
2025
Rating:
Not achieved